Transient receptor potential vanilloid 6 (TRPV6) functions in tetramer form for calcium transport. 
.
Fetal skeleton mineralization depends upon fetal plasma calcium sourced through active placental transfer, long attributed to parathyroid hormone (PTH) and PTH-related peptide activity (Simmonds & Kovacs, 2010) . Recently identified additional factors include calbindin (intracellular calcium binding protein), sodium/calcium exchangers (Koo et al., 2012) , and TRPV6 (sixth member of the transient receptor potential vanilloid subfamily) (Montell, Birnbaumer, & Flockerzi, 2002) .
TRPV6 is relevant to calcium absorption (Fecher-Trost, Wissenbach, & Weissgerber, 2017) . TRPV6 gene location and expression varies across species; in humans, TRPV6 is situated on chromosome 7q33-q34 and is expressed in prostate, placenta, epididymis, and exocrine pancreas (Wissenbach et al., 2001) . Research has focused on the potential contribution of TRPV6 overexpression in prostate and breast cancer. Fewer reports address underexpression: the trpv6 −/− knockout mouse has hypofertility due to altered calcium homeostasis in the epididymis and in humans reduced placental expression is associated with preeclampsia (Haché et al., 2011 Neonatal severe hyperparathyroidism (NSHPT) was considered, based on marked PTH elevation and periosteal abnormalities, despite the absence of hypercalcemia; pamidronate single dose Day 16 then daily cinacalcet (calcimimetic) were used preemptively to avoid anticipated severe hypercalcemia (Fisher, Cabrera, & Imel, 2015) .
PTH normalized, serum calcium did not rise, including after cinacalcet cessation. Transient mild hypocalcemia and hypophosphatemia occurred at weeks 3-4.
At the age of 6 weeks, X-rays showed improved rib mineralization Whole exome sequencing was performed with DNA samples from the patient and her unaffected parents using the Agilent SureSelect All Exon v6 system, with sequencing on an Illumina NextSeq 500.
Likely causative variants were confirmed by Sanger sequencing.
| RESULTS
Antenatal genetic tests were normal including Array comparative genomic hybridization (aCGH) and investigation for paternal UPD14
(Kagami-Ogata syndrome), undertaken in view of the thoracic appearance.
Postnatally, careful clinical assessment suggested skeletal developmental pathology was the likely primary mechanism resulting in small lungs instead of primary lung pathology (pulmonary hypoplasia). 
| DISCUSSION
This case adds significantly to understanding of TRPV6 function in humans. We hypothesize that structural/quantitative alterations in TRPV6 in our patient reduced placental calcium transfer and resulted in severely compromised in utero skeletal development and Identification of compound heterozygous TRPV6 variants in this patient coincides with new information on how TRPV6 operates for calcium transfer. TRPV6 crystal structure has been recently described (McGoldrick et al., 2017; Saotome et al., 2016) . The gene changes in our patient lie at the tetrameric interface crucial for calcium channel function (McGoldrick et al., 2017) and are predicted to destabilize the protein complex resulting in loss of calcium transport.
Although trpv6 is expressed in many mouse tissues, including intestine, expression in humans appears restricted to placenta, exocrine pancreas, and some exocrine glands (Fecher-Trost et al., 2017) .
Our case showed effects of compromised placental calcium transfer, but did not demonstrate any exocrine pancreatic dysfunction features such as intestinal malabsorption. The absence of preeclampsia does not reinforce the hypothesis of TRPV6 dysfunction in preeclampsia (Haché et al., 2011 (Krakow et al., 2009; Lamandé et al., 2014; Zimo n et al., 2010) . Severe perinatal skeletal dysplasia has not been reported in association with TRPV6. Our case has intriguing similarities to severe antenatal-onset Caffey disease including polyhydramnios, hyperostosis, periosteal reaction, and progressive resolution of bony lesions over time (Schweiger et al., 2003) , although we did not observe soft tissue swellings or fever. Antenatal Caffey disease is very rare and although heterozygote COL1A1 mutations have been identified in some cases (Gensure et al., 2005) , genetic heterogeneity seems likely and TRPV6 may be a candidate worth investigation in unsolved cases.
Combined clinical and genetic expertise achieved diagnostic precision for this case and contributes to understanding of TRPV6 in human disease. 
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